The use of an immunomodulator compound of Formula (A) for treating lung cancer and lung cancer metastasis. R is hydrogen, C2-10 acyl or C1-6 alkyl n is 1 or 2 and X is L-tryptophan or D-tryptophan. The compound can be gamma-D-glutamyl-L-tryptophan (SCV-07).